ArticleInternational journal of oncology2014
Breast cancer in European Union: an update of screening programmes as of March 2014 (review).
Article in International journal of oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Informing prostate cancer screening policy makers in the European Union: lessons from cancer screening governance and policymaking.European journal of public health · 2025Pooled it
- Risk Factors for Abdominal Aortic Aneurysm in Population-Based Studies: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2018Pooled it
- Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis.BMC cancer · 2017Pooled it
- Breast Cancer Screening Programmes across the WHO European Region: Differences among Countries Based on National Income Level.International journal of environmental research and public health · 2017Pooled it
- Two Decades of Female Breast Cancer Mortality in Hungary: Epidemiological Trends Since EU Accession.Cancers · 2025Article
- Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain.Breast cancer research and treatment · 2024Article
- Estimating disparities in breast cancer screening programs towards mortality, case fatality, and DALYs across BRICS-plus.BMC medicine · 2023Article
- Breast Cancer Screening and Perceptions of Harm among Young Adults in Japan: Results of a Cross-Sectional Online Survey.Current oncology (Toronto, Ont.) · 2023Article
- Results of the National Breast Cancer Screening Program in Croatia (2006-2016).Croatian medical journal · 2022Article
- Article
- Does retirement affect secondary preventive care use? Evidence from breast cancer screening.Economics and human biology · 2021Article
- Personalized Screening for Breast Cancer: Rationale, Present Practices, and Future Directions.Annals of surgical oncology · 2021Review
- Participation in lung cancer screening.Translational lung cancer research · 2021Review
- Predictors of Mammography Uptake Among Italian Women Aged 50-69: a Cross-sectional Study.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020Article
- Article
- Health information provision, health knowledge and health behaviours: Evidence from breast cancer screening.Social science & medicine (1982) · 2020Article
- Croatian success in early breast cancer detection: favorable news in Breast Cancer Awareness Month.Croatian medical journal · 2020Article
- Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries.SAGE open medicine · 2020Article
- Breast cancer mortality trends in Europe among women in perimenopausal and postmenopausal age (45+).Archives of medical science : AMS · 2020Article
- National Breast Screening Programs across Europe.Breast care (Basel, Switzerland) · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer, a major cause of female morbidity and mortality, is a global health problem; 2008 data show an incidence of ~450,000 new cases and 140,000 deaths (mean incidence rate 70.7 and mortality rate 16.7, world age-standardized rate per 100,000 women) in European Union Member States. Incidence rates in Western Europe are among the highest in the world. We review the situation of BC screening programmes in European Union. Up to date information on active BC screening programmes was obtained by reviewing the literature and searching national health ministries and cancer service websites. Although BC screening programmes are in place in nearly all European Union countries there are still considerable differences in target population coverage and age and in the techniques deployed. Screening is a mainstay of early BC detection whose main weakness is the rate of participation of the target population. National policies and healthcare planning should aim at maximizing participation in controlled organized screening programmes by identifying and lowering any barriers to adhesion, also with a view to reducing healthcare costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.